Login
$DXCM
$81.60 -$0.01 (0.01%) After hours

Company Executives

Officer Age In this role Joined 2025 pay Source
Jacob Leach Also a director
President and Chief Executive Officer
48 Not stated Not stated $7,985,960
Jereme Sylvain
Executive Vice President, Chief Financial Officer
46 Not stated 2018 $7,077,902
Kevin Sayer Also a director
Executive Chairman of the Board
68 Not stated Not stated $16,282,598
Jon Coleman
Executive Vice President, Chief Commercial Officer
62 Since 2025
1 year
Not stated $6,745,295
Michael Brown
EVP Chief Legal Compliance Off
Title from the Form 4 dated Nov 8, 2026
56 Not stated 2022 $6,343,856
Sadie Stern
EVP Chief People & Culture Off
Title from the Form 4 dated Nov 8, 2026
51 Not stated Not stated $6,253,131

Each officer opens the passage of the filing that names them. A title that changed since the list comes from the officer's latest Form 3, 4 or 5, and its start year is not stated there. "Not stated" means the filing does not say. Pay is the proxy's Summary Compensation Table, which reports only the named executive officers.

Board of Directors

From the proxy statement filed Apr 15, 2026 · updated by the 8-K of Sep 10, 2026

Directors
13
serving now
Independent
9 of 11
stated in the proxy; 2 not stated
Average tenure
7.3 years
from year joined
CEO also chairs the board
No
Kevin Sayer
Director Age On board Independent Committees Other public boards Pay Source
Kevin Sayer
68 2007
19 years
Not independent None stated None stated Not stated
Jacob Leach
48 2026
this year
Not independent None stated SenesTech, Inc. Paid as CEO
Mark Foletta
65 2014
12 years
Independent None stated AMN Healthcare Services Not stated
Steven Altman
64 2013
13 years
Independent None stated None stated Not stated
Euan Ashley
54 2025
1 year
Independent None stated AstraZeneca Plc Not stated
Nicholas Augustinos
67 2009
17 years
Independent None stated None stated Not stated
Richard Collins
69 2017
9 years
Independent None stated None stated Not stated
Rimma Driscoll
53 2023
3 years
Independent None stated None stated Not stated
Renée Galá
54 2025
1 year
Independent None stated Jazz Pharmaceuticals PLC Not stated
Bridgette Heller
64 2019
7 years
Independent None stated Aramark Not stated
Kyle Malady
59 2020
6 years
Not stated None stated None stated Not stated
Rick Osterloh
53 2026
this year
Not stated None stated None stated Not stated
Glenn S. Boehnlein Joined Sep 10, 2026
- - Independent
Operations & Innovation Committee Audit Committee
- -

Each director opens the passage of the proxy that names them. "Not stated" means the proxy does not say; it never means "no". Pay is the proxy's Director Compensation table; the CEO is paid as an executive. A director marked Joined was added by an 8-K; their row opens that 8-K, and a dash is a value it does not give.

No related-party transactions disclosed

The proxy filed Apr 15, 2026 states there were none.

Read it in the proxy

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support